Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group (Q45753199)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 1998

Language	Label	Description	Also known as
English	Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group	scientific article published in October 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

Eric A F Simões

1

object named as

Simoes EA

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

author name string

Sondheimer HM

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

Top FH Jr

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

Meissner HC

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

Welliver RC

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

Kramer AA

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

Groothuis JR

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

language of work or name

0 references

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

The Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

133

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

492-499

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Respiratory syncytial viral infection in children with compromised immune function

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Respiratory syncytial viral infection in infants with congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Interference of immune globulin with measles and rubella immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Effect of high-dose intravenous immunoglobulin therapy on blood rheology

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Hyperviscosity in congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970056-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-3476(98)70056-3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9787686

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45753199&oldid=2081000600"